Authors

Lifting Barriers to Equitable Care in Epilepsy

Four neurologists treating patients with epilepsy share their experience in and out of the clinic tackling issues of access for their patients.

Bruton Tyrosine Kinase Inhibitors: A New Hope for the Management of Progression in MS?

Several therapies are progressing through the development pipeline and have shown promising data, setting up the multiple sclerosis treatment toolbox for possible expansion in coming years.

Clinical Perspective of Insomnia in Sleep Medicine

Alexander Scheer, MD, medical director at Scheer Medical Wellness, provided his medical perspective on insomnia in the clinical practice of sleep medicine.

Exploring Tools to Target the Glymphatic System and Alzheimer Disease Risk: Andrew Varga, MD

The associate professor of medicine at the Icahn School of Medicine at Mount Sinai outlined emerging interventions aimed at enhancing glymphatic clearance to potentially lower Alzheimer disease risk. [WATCH TIME: 4 minutes]

A New Approach to Protein Misfolding in Parkinson Disease

Previously, many promising treatments for PD have ultimately resulted in untenable adverse effects or in failure, but the evolving area of protein folding offers an opportunity to slow or reverse the neurodegenerative process.

Less Invasive Epilepsy Surgery May Help Turn Candidates Into Consults

Recent advances in stereoelectroencephalography and laser ablation may help convert those who may be candidates for pediatric epilepsy surgery to those who proceed with a consultation.

The Role of Music & Movement in Parkinson Disease Treatment

Kenneth Ngo, MD, medical director for the Brain Injury Program at Brooks Rehabilitation’s 3 inpatient hospitals, highlighted how cotreatment between music therapy and physical therapy can significantly improve the overall quality of life for patients with Parkinson disease.

Testing GLP-1 Receptor Agonists for Other Cardiovascular and Stroke-Related Conditions: Dennis Rivet, MD

The Harold I. Nemuth Chair in Neurological Disorders at Virginia Commonwealth University provided hypothetical insights on potential stroke-related avenues for GLP-1 RAs to treat following positive data in idiopathic intracranial hypertension. [WATCH TIME: 4 minutes]

Innovations in Glioblastoma Research

Glioblastoma, a highly aggressive brain cancer, presents substantial treatment challenges necessitating innovative therapies and interdisciplinary research to improve patient outcomes.

Sparing the Hippocampus in Epilepsy Surgery: Critical Decisions for Outcome Optimization

Surgical treatment for epilepsy has been proven its effectiveness, and preoperative evaluation has sparked a debate: to spare or not to spare the hippocampus?

Bridging Sleep Science and Biomarkers in Neurodegeneration: Lea Grinberg, MD, PhD

The neuropathologist at Mayo Clinic Florida discussed why EEG-based sleep biomarkers may help detect Alzheimer disease earlier and how they could enhance clinical trial design. [WATCH TIME: 3 minutes]

The Current State and Future Promise of Magnetoencephalography (MEG) in Epilepsy and Beyond

Magnetoencephalography provides an opportunity for physicians to capture a more dynamic view of brain function over time and space that may offer an advantage to clinical care.

NeurologyLive® Clinician of the Month Spotlight: Forum Kamdar, MD, PhD, FACC, FHFSA

As part of our monthly clinician spotlight, NeurologyLive® highlighted neuromuscular-associated cardiomyopathy expert Forum Kamdar, MD, PhD, FACC, FHFSA, an advanced heart failure physician-scientist at the University of Minnesota.

Applying the Innovation Biodesign Framework to Promote Equity and Green Activity in Dementia Care

Lassell et al present a use case demonstrating the process of moving an unmet need to the “solution space” of the Innovation Biodesign Framework for addressing a healthcare challenge in a specific at-risk population: Alzheimer disease and AD-related dementias.

A Rationale and Step-by-Step Strategy for Including Care Partners in MS Care

Engaging care partners in multiple sclerosis treatment enhances patient outcomes and supports their well-being, fostering healthier care partnerships.

The Label of ‘Caregiver’

Rebecca Whitney, associate director of Programs and Community Support at SRNA and mother of child with a rare neuroimmune disorder, provided thoughts on the importance of caregivers and the role they play in everyday life.

Helping Patients Identify and Manage Parkinson’s Disease OFF Episodes

Identifying Small Clinical Characteristics to Facilitate Early Myasthenia Gravis Diagnosis: Judith Thompson, PharmD, MPH, CPHQ

The rare disease population health strategy lead at UCB provided clinical insight on some of the unique challenges of diagnosing myasthenia gravis, and some of the early signs clinicians and non-specialists should look out for. [WATCH TIME: 3 minutes]

Looking Ahead: How Consensus Guidelines Will Shape the Future of SMA Care

This closing episode looks ahead to the future of SMA care, examining how updated best practices aim to accelerate access, optimize outcomes, and fuel ongoing progress.

An Overview of Therapeutic Options for Amyotrophic Lateral Sclerosis

With an anticipated life expectancy of 3 years from the time of symptom onset, an effective treatment strategy is essential in ALS—and recent therapeutic progress has built a foundation of hope for the community.

A Changing Clinical Landscape: Promising Therapeutic Avenues in the Treatment of DIPG and Other Diffuse Midline Gliomas

A duo of experts from Weill Cornell Medicine talked about the advancements made in diffuse midline gliomas research and clinical trials that may offer new hope for improving its historically poor prognosis.

Lifestyle Change for Migraine Management: Practical Tips for the Neurologist and PCP, Part 2

Trigger avoidance-only strategies don’t actually help migraine patients improve. These are the proactive behaviors that do.

Current and Future Landscape of Alzheimer Disease Treatment: Emergence of Disease Modifying Therapies

After years of failed drug development, the thoughts of disease-modifying therapies for Alzheimer disease are starting to become real.

Managing MS in Millennials

Effectively navigating the nuances of this unique patient population will ultimately help drive innovative solutions for this generation and those to come.

Clinical Experience and Considerations With ALS Medication Tofersen: Sandeep Rana, MD

The neurophysiologist at Allegheny Health Network shared his clinical experience with tofersen in patients with SOD-1 ALS, while emphasizing the critical role of accessible genetic testing for patient identification. [WATCH TIME: 3 minutes]

Challenges and Opportunities Bringing Lecanemab to Neurology Community Clinics 

A group of experts from The Neuron Clinic shared their experience developing a novel inclusive clinical program to treat patients with early Alzheimer disease using lecanemab.